About the Product

Description


Darbepoetin Alfa 40mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce red blood cells, helping improve hemoglobin levels and enhancing oxygen delivery throughout the body.

This injection is commonly prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia therapy, helping reduce fatigue and improve overall patient quality of life.

With strong clinical importance in nephrology and oncology treatment protocols, consistent hospital demand, and wide acceptance among specialists, this formulation strengthens institutional care portfolios and supports sustained therapeutic utilization.


Some patients may experience headache, increased blood pressure, injection site discomfort, nausea, or fatigue. In rare cases, allergic reactions, blood clots, or severe hypertension may occur and require medical attention.

Darbot 40 Injection is indicated for the treatment of anemia associated with chronic kidney disease in patients on dialysis as well as those not undergoing dialysis. It is also used to manage anemia in patients receiving chemotherapy for specific types of cancer, helping improve red blood cell levels and reduce symptoms of anemia.

This injection should be administered under the supervision of a qualified healthcare professional. Regular monitoring of hemoglobin levels and blood pressure is recommended during treatment. The dosage should be determined and adjusted by a physician based on the patient’s clinical condition and response to therapy.

Store in a refrigerator at 2°C–8°C. Do not freeze and protect from light. Keep the injection in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Darbepoetin Alfa 40mcg Injection in the PCD pharma franchise market?

Darbepoetin Alfa 40mcg Injection has strong demand in the nephrology and hospital critical care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include Darbepoetin Alfa Injection in their product range?

Medical distributors and wholesalers can benefit from consistent demand in anemia management, especially in chronic kidney disease (CKD), dialysis patients, and oncology supportive care. It strengthens their hospital injectable portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Darbepoetin Alfa 40mcg Injection?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Darbepoetin Alfa 40mcg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this injection?

Wholesalers and medical agencies benefit from steady hospital demand, long-term chronic therapy usage, and strong institutional sales opportunities when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Darbepoetin Alfa Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this nephrology/hematology injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.